Similar Papers

Paper Title
Journal
Date
Author
Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.
İsmail Ağababaoğlu ... Ahmet Önen
Medicine | VOL. 96
İsmail Ağababaoğlu, et. al.İsmail Ağababaoğlu ... Ahmet Önen
01 Feb 2017
Lepidic component identifies a subgroup of lung adenocarcinoma with a distinctive prognosis: a multicenter propensity-matched analysis.
Erjia Zhu ... Quan Zhu
Therapeutic advances in medical oncology | VOL. 12
Erjia Zhu, et. al.Erjia Zhu ... Quan Zhu
01 Jan 2020
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas
Naoya Miyashita ... Takahide Nagase
Journal of Thoracic Oncology | VOL. 13
Naoya Miyashita, et. al.Naoya Miyashita ... Takahide Nagase
16 Aug 2018
Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
Chen Huo ... Meng-Yu Zhang
Frontiers in Cell and Developmental Biology | VOL. 9
Chen Huo, et. al.Chen Huo ... Meng-Yu Zhang
22 Jul 2021
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
HIV Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in Non-Small Cell Lung Cancer
Baptiste Abbar ... Brigitte Autran
Journal of Thoracic Oncology | VOL. -
Baptiste Abbar, et. al.Baptiste Abbar ... Brigitte Autran
01 Feb 2025
Safety, Pharmacokinetics, and Efficacy of TY-9591 (Deuterated Osimertinib Derivative) in Advanced EGFR-mutated Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study
Baohui Han ... Yusheng Wu
Journal of Thoracic Oncology | VOL. -
Baohui Han, et. al.Baohui Han ... Yusheng Wu
01 Feb 2025
Meeting Announcements
-
Journal of Thoracic Oncology | VOL. 20
--
01 Feb 2025
First-Line Camrelizumab versus Placebo Plus Chemotherapy with or without Radiotherapy for Brain Metastases in Non-Small-Cell Lung Cancer: The CTONG 2003 Randomized Placebo-Controlled Trial
Yang-Si Li ... Yi-Long Wu
Journal of Thoracic Oncology | VOL. -
Yang-Si Li, et. al.Yang-Si Li ... Yi-Long Wu
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.